PCDHGA9: A Potential Drug Target and Biomarker for Cancer (G56107)

Target Name: PCDHGA9

NCBI ID: G56107

PCDHGA9

PCDHGA9: A Potential Drug Target and Biomarker for Cancer

PCDHGA9 (PCDHGA9 variant 1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The PCDHGA9 gene is located on chromosome 16 and encodes for the protein PDGF-A, which is a key regulator of cell proliferation and survival.

PDGF-A is a transmembrane protein that plays a crucial role in the development and maintenance of tissues and organs, including neural cells, tissues, and organs. It is involved in the formation and maintenance of tissues and organs during development, and is also involved in the regulation of cell growth, differentiation, and survival.

Research has shown that PCDHGA9 is involved in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of PCDHGA9 are associated with the development of pancreatic cancer, and that inhibition of the PDGF-A pathway has been shown to be effective in treating this type of cancer.

In addition to its potential as a cancer drug target, PCDHGA9 has also been identified as a potential biomarker for the disease. The PDGF-A pathway is involved in the regulation of many different proteins, including those involved in cell adhesion, migration, and invasion. Therefore, measuring levels of PDGF-A and its downstream targets, such as PCDHGA9, can be a useful diagnostic tool for cancer and other diseases.

PCDHGA9 has also been shown to be involved in the regulation of stem cell proliferation and differentiation. It is a known regulator of the stem cell factor (SCF) receptor, which is involved in the survival and proliferation of stem cells.

In addition to its potential as a drug target and biomarker, PCDHGA9 is also of interest to researchers as a potential therapeutic target for other diseases. For example, PCDHGA9 has been shown to be involved in the regulation of cell migration and invasion, which are important processes in the development of many diseases, including cancer.

In conclusion, PCDHGA9 is a gene that has been identified as a potential drug target and biomarker for the treatment of various diseases, including cancer. Its involvement in the regulation of cell proliferation and survival makes it an attractive target for small molecule inhibitors. Further research is needed to fully understand the role of PCDHGA9 in the development and progression of disease.

Protein Name: Protocadherin Gamma Subfamily A, 9

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHGA9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHGA9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets